An AI-based EGFR biomarker tool could preclude the need for a rapid PCR test in nearly half of advanced lung adenocarcinoma cases, a study has suggested.

The update strengthens IBTROZI's position as a next-generation treatment in a rare, aggressive lung cancer that often spreads ...

Lung cancer may be curable, depending on a number of factors, including your age, health, stage of cancer, and how it ...

Onco360®, the nation’s leading independent specialty pharmacy, has added Augtyro™ (repotrectinib) manufactured by Bristol ...

Nuvalent Inc. (NASDAQ:NUVL) is one of the best high short interest stocks with huge upside potential. On June 24, Nuvalent ...

BrightSpring Health Services Inc. (NASDAQ:BTSG) is a home and community-based healthcare services platform in the US that ...

Nuvation Bio Inc. (NYSE: NUVB) is one of the 10 best healthcare penny stocks to buy according to analysts. JMP Securities ...

Detailed price information for Nuvation Bio Inc (NUVB-N) from The Globe and Mail including charting and trades.

To detect ROS1 rearrangement in NSCLC, three different assays including fluorescent in stiu hybridization (FISH), Amoy Dx reverse transcription polymerase chain reaction (RT-PCR) and Oncomine Dx ...

The completed Phase 1 portion enrolled ROS1-positive NSCLC patients who previously received at least one ROS1 TKI, or patients with other ROS1-positive solid tumors who had been previously treated.